Items without sitelinks

Jump to navigation Jump to search

Showing below up to 50 results starting with #5,001.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. Introduction 35 (from mdp.39015020866227) (Q11343)
  2. Headings and Uniform Titles (from mdp.39015020866227) (Q11342)
  3. PART II (from mdp.39015020866227) (Q11341)
  4. 1 Description of Archival Material 7 (from mdp.39015020866227) (Q11340)
  5. Introduction 3 (from mdp.39015020866227) (Q11339)
  6. Acknowledgements ix (from mdp.39015020866227) (Q11338)
  7. testq (Q11334)
  8. templabel (Q11329)
  9. Zhou F, et al, Lancet (2020), cited as Ref 8 in DOI: 10.1097/AOG.0000000000003924 (Q11327)
  10. Heyrana K, et al, JAMA (2018), cited as Ref 7 in DOI: 10.1097/AOG.0000000000003924 (Q11326)
  11. Blehar MC, et al, Women's Health Issues (2013), cited as Ref 6 in DOI: 10.1097/AOG.0000000000003924 (Q11325)
  12. Gomes MF, et al, Reprod Health (2017), cited as Ref 5 in DOI: 10.1097/AOG.0000000000003924 (Q11324)
  13. Illamola SM, et al, Br J Clin Pharmacol (2018), cited as Ref 4 in DOI: 10.1097/AOG.0000000000003924 (Q11323)
  14. Scaffidi J, et al, BJOG (2017), cited as Ref 3 in DOI: 10.1097/AOG.0000000000003924 (Q11322)
  15. Rasmussen SA, et al, Am J Obstet Gynecol (2020), cited as Ref 2 in DOI: 10.1097/AOG.0000000000003924 (Q11321)
  16. World Health Organization. (2020), cited as Ref 1 in DOI: 10.1097/AOG.0000000000003924 (Q11320)
  17. Saade GR (3rd author of DOI: 10.1097/AOG.0000000000003924) (Q11319)
  18. Landon MB (2nd author of DOI: 10.1097/AOG.0000000000003924) (Q11318)
  19. Costantine MM (1st author of DOI: 10.1097/AOG.0000000000003924) (Q11317)
  20. References (from DOI: 10.1084/jem.20200653) (Q11182)
  21. Section 4: COVID-19 treatment by IFN-lambda: Pros and cons (from DOI: 10.1084/jem.20200653) (Q11181)
  22. Section 3: IFN-lambda as an antiviral drug (from DOI: 10.1084/jem.20200653) (Q11180)
  23. Section 2: IFNs as natural broad-spectrum antivirals (from DOI: 10.1084/jem.20200653) (Q11179)
  24. Section 1: Introduction (from DOI: 10.1084/jem.20200653) (Q11178)
  25. angiotensinogen (gene) (Q11164)
  26. Melkersson-Rosenthal syndrome (gene) (Q11163)
  27. ORF1ab polyprotein (gene) (Q11162)
  28. CD1 antigen complex (gene) (Q11161)
  29. Porcine reproductive and respiratory syndrome virus (species) (Q11160)
  30. Murine hepatitis virus (species) (Q11159)
  31. Betaarterivirus suid 1 (species) (Q11158)
  32. Equus caballus (species) (Q11157)
  33. Sus scrofa (pig) (species) (Q11156)
  34. Vaccinia virus (species) (Q11155)
  35. Porcine parvovirus (species) (Q11154)
  36. Felis catus (species) (Q11153)
  37. Murine coronavirus (species) (Q11152)
  38. Feline infectious peritonitis virus (species) (Q11151)
  39. Infant, Newborn, Diseases (disease - MeSH descriptor) (Q11150)
  40. Pneumothorax (disease - MeSH descriptor) (Q11149)
  41. Chorioamnionitis (disease - MeSH descriptor) (Q11148)
  42. Lethargy (disease - MeSH descriptor) (Q11147)
  43. Rubella (disease - MeSH descriptor) (Q11146)
  44. Tachycardia (disease - MeSH descriptor) (Q11145)
  45. Muscle Hypotonia (disease - MeSH descriptor) (Q11144)
  46. Anemia (disease - MeSH descriptor) (Q11143)
  47. Viremia (disease - MeSH descriptor) (Q11142)
  48. Lactation Disorders (disease - MeSH descriptor) (Q11141)
  49. Hepatitis, Viral, Human (disease - MeSH descriptor) (Q11140)
  50. Chemical and Drug Induced Liver Injury (disease - MeSH descriptor) (Q11139)

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

Retrieved from "http://wikibase.slis.ua.edu/wiki/Special:ItemsWithoutSitelinks"